Scientists Uncover Exciting Cancer Treatment Breakthrough in Frog Gut Bacteria
A groundbreaking discovery in the fight against cancer has emerged from the gut bacteria of a Japanese tree frog, offering hope for a new approach to combating this deadly disease. Researchers found that a specific strain of bacteria completely eradicated tumors in mice, without causing severe side effects.
The Japanese tree frog, scientifically known as Dryophytes japonicus, was chosen for this study due to the rarity of cancer development in amphibians and reptiles. Scientists from the Japan Advanced Institute of Science and Technology investigated whether transferring gut bacteria from frogs to mice could have anti-cancer properties.
Out of 45 different bacterial strains from frogs, newts, and lizards that were tested, 9 strains exhibited significant tumor-fighting capabilities. Among these strains, the most remarkable was a bacteria called Ewingella americana.
The research, published in Gut Microbes, highlights the potential therapeutic benefits of exploring the gut microbiomes of lower vertebrates for cancer treatment.
The remarkable results of the study showed that E. americana not only shrunk tumors in treated mice but completely eliminated them. Even when cancer cells were reintroduced a month later, no new tumors developed in the treated mice.
Further analysis revealed that E. americana operates by attacking tumor tissue and enhancing the body’s immune response, activating key immune cells like T cells, B cells, and neutrophils.
The effectiveness of E. americana is attributed to its ability to thrive in low-oxygen environments, such as cancer tumors, where it can boost immune responses that are typically suppressed by tumors.
Initial animal studies demonstrated that E. americana was safe, as it was quickly cleared from the bloodstream, did not cause long-lasting toxicity, and did not affect healthy organs. Moreover, injections of E. americana proved more effective at reducing tumors in mice compared to traditional treatments like doxorubicin.
While these findings hold promise, extensive testing is required to determine the potential translation of this treatment to humans. Future studies will explore the efficacy of E. americana against other types of cancers, its compatibility with existing treatments, and optimal delivery methods.
Safety remains a top priority as bacterial treatments advance towards clinical trials, considering the potential risk of infections associated with bacterial therapies. Scientists are also investigating alternative bacterial therapies for cancer treatment, with some already being utilized for bladder cancer.
The discovery of cancer-fighting properties in frog gut bacteria underscores the importance of biodiversity conservation in medical innovation and therapeutic development. The research sheds light on the untapped potential within diverse microbial ecosystems and highlights the value of exploring novel sources for cancer therapeutics.
The study has been published in Gut Microbes.
